Sandoz Gmbh, based in Switzerland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for A global leader in antibiotics.
One of their notable products is AMPICILLIN SODIUM (STERILE), with a corresponding US DMF Number 13754.
Remarkably, this DMF maintains an Active status since its submission on September 01, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 20, 2023, and payment made on April 17, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II